• No results found

[PDF] Top 20 A Prospective study of Sexual Dysfunction in Patients with Benign Prostatic Hyperplasia

Has 10000 "A Prospective study of Sexual Dysfunction in Patients with Benign Prostatic Hyperplasia" found on our website. Below are the top 20 most common "A Prospective study of Sexual Dysfunction in Patients with Benign Prostatic Hyperplasia".

A Prospective study of Sexual Dysfunction in Patients with Benign Prostatic Hyperplasia

A Prospective study of Sexual Dysfunction in Patients with Benign Prostatic Hyperplasia

... This is to certify that this dissertation “A PROSPECTIVE STUDY OF SEXUAL DYSFUNCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA” submitted by Dr. J. SARAVANAN ... See full document

113

Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia

Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia

... Benign prostatic hyperplasia (BPH) and prostate cancer (PCa) represent the most common urologic diseases among the elderly males resulting in more than 2 million visits per year; 8 % of the total ... See full document

7

 BENIGN PROSTATIC HYPERPLASIA: UPDATED REVIEW

 BENIGN PROSTATIC HYPERPLASIA: UPDATED REVIEW

... elderly patients with BPH are poor surgical candidates, and manyyounger patients find the risk of sexual dysfunction associated with TURP to ...younger patients in whom fertility and ... See full document

7

Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan

Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan

... 50 patients who discontinued naftopidil during the follow-up, only 13 (26%) patients reported that they needed retreatment with α1-blockers and/or surgery within 3 ... See full document

8

Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations

Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations

... controlled study. The patients were randomized into receiving the combination therapy or tamsulosin for 45 days, and then switched to the other group for another 45 ... See full document

6

Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi center study

Comparison of outpatient versus inpatient transurethral prostate resection for benign prostatic hyperplasia: Comparative, prospective bi center study

... The patients were given initial assessments, which included International Prostate Symptom Scores (IPSS), the 8th question of IPSS (QoL), maximal urinary flow rates (Qmax) and post-voiding residual urine volume ... See full document

6

Management of benign prostatic hyperplasia with silodosin

Management of benign prostatic hyperplasia with silodosin

... our study with silodosin, Qmax increased significantly from ...urodynamic study (n = 29), maximum cystometric capacity increased significantly (p = ...20 patients (40%) and improved (bladder capacity ... See full document

7

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction

... for patients taking BPH and/or ED drugs and 4-week placebo run-in period, patients were assigned to once-daily placebo or tadalafil ...of patients had moderate ED (IIEF score of between 11 and 16): ... See full document

13

Herbal Management of Benign Prostatic Hyperplasia

Herbal Management of Benign Prostatic Hyperplasia

... most patients will ultimately undergo BPH-related surgery ...ejaculatory dysfunction, erectile dysfunction and gynecomastia thus these side effects should be monitored when using these drugs ... See full document

5

Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study

Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study

... This prospective controlled study was approved by the Ethical Committee of Gülhane Military Medical Acade- my, protocol number 1491-1175-10/1539, and conducted in accordance with the Declaration of ...the ... See full document

5

<p>The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia</p>

<p>The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia</p>

... recent study of univariable and multivariable linear regression analysis, age was found to be the only risk factor associated with newly-reported ED in 12 months after P-TUR ...13 Patients who were older ... See full document

6

Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open Label Study

Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open Label Study

... of patients. In both the 50 mg and 75 mg groups, >86% of all patients agreed to continue their current ...BPH patients with hypertension allows for optimal management of BP within the normal ... See full document

7

MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY

MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY

... this study 49 patients underwent laser cystolithotripsy procedure for urinary bladder stones with the mean patient age was 46 years (58 ± 7 years) receiving Silodosin 8 mg once daily (5 patients were ... See full document

5

Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia

Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia

... TURP patients did. PVP patients had a significantly lower likelihood of clot reten- ...scores. Sexual function and prostate specific antigen value changes were ... See full document

25

IMPLICATION OF PROSTATE SPECIFIC ANTIGEN IN BENIGN PROSTATIC HYPERPLASIA

IMPLICATION OF PROSTATE SPECIFIC ANTIGEN IN BENIGN PROSTATIC HYPERPLASIA

... However, benign prostatic adenoma frequently develops in the prostate in older ...men.Benign Prostatic Hyperplasia (BPH) is the commonest benign tumor in the ageing male and is ... See full document

7

Diagnosis and management of benign prostatic hyperplasia in primary care

Diagnosis and management of benign prostatic hyperplasia in primary care

... Treatment with finasteride in the 4-year Proscar Long-Term Efficacy and Safety Study (PLESS), reduced prostate volume by 18% (v. a 14% increase with placebo; p < 0.0001), improved AUA-SI symp- tom scores (2.6 ... See full document

9

Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?

Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?

... Our study had some limitations. First, due its obser- vational nature, the associations observed between MetS and BPH may not be causal, on account of some unknown confounding or reverse causality. Second, there ... See full document

7

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia

... of tamsulosin 0.2 mg) or a tamsulosin-preceding group (four weeks’ administration of tamsulosin followed by four weeks’ administration of silodosin). Forty-six patients were assigned to the silodosin-preceding ... See full document

12

Comparison of Matrix Metalloproteinases 2 mRNA Expression in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia

Comparison of Matrix Metalloproteinases 2 mRNA Expression in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia

... Prostate cancer is the second most common (after skin cancer) and the second most fatal (after lung cancer) cancer in men in developed countries. One in every six men is affected by this cancer [1]. The highest ... See full document

12

THE POSSIBLE BENEFICIAL EFFECTS OF SELENIUM SUPPLEMENTATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA USING FINASTERIDE

THE POSSIBLE BENEFICIAL EFFECTS OF SELENIUM SUPPLEMENTATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA USING FINASTERIDE

... 45. Benign prostatic hyperplasia (BPH) is a non-cancerous progressive condition affecting the majority of men as they are over the age of 50, due to an imbalance between cell proliferation and ... See full document

21

Show all 10000 documents...